Pulmonary Infections

ANTI-FUNGAL THERAPEUTICS

COMPOUND INDICATION PRE – CLINICAL CLINICAL
TC-PMY-116*
Invasive Pulmonary Aspergillosis (IPA)
TC-PMY-119*
Allergic Bronchopulmonary Aspergillosis (ABPA)
TC-PMY-121*
Esophageal Candidiasis
TC-PMY-123*
Pulmonary Cryptococcosis
* We hold rights to develop this molecule pursuant to an agreement with a drug-design firm.
We are developing a novel inhalation therapeutic for treating certain fungal infections in immunocompromised patients.
Hi, How Can We Help You?
error: Content is protected !!